Caitong International Asset Management Co., LTD Moon Lake Immunotherapeutics Transaction History
Caitong International Asset Management Co., LTD
- $144 Billion
- Q3 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 84,553 shares of MLTX stock, worth $1.08 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
84,553
Previous 376
22387.5%
Holding current value
$1.08 Million
Previous $17.7 Million
3316.04%
% of portfolio
0.42%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding MLTX
# of Institutions
180Shares Held
38.5MCall Options Held
4.13MPut Options Held
1.51M-
Bvf Inc San Francisco, CA19.8MShares$252 Million7.66% of portfolio
-
Avoro Capital Advisors LLC New York, NY2MShares$25.5 Million0.2% of portfolio
-
Cormorant Asset Management, LP Boston, MA1.99MShares$25.5 Million2.28% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.7MShares$21.7 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.5MShares$19.2 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $472M
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...